Best Use of Adjuvant Endocrine Therapy in HR-low Breast Cancer? Best Use of Adjuvant Endocrine Therapy in HR-low Breast Cancer?
The findings shed light on a contentious debate. The study was published as a preprint and has not yet been peer reviewed.First Look
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
More News: Breast Cancer | Cancer | Cancer & Oncology | Endocrine Therapy | Health | Hematology | Study